Global Post-Traumatic Stress Disorder (PTSD) Market Research Report 2023

Post-Traumatic Stress Disorder (PTSD) Market

Post-traumatic stress disorder (PTSD) is a delayed and persistent mental disorder that occurs when an individual experiences, witnesses, or encounters one or more actual deaths involving himself or others, or is threatened with death, or is severely injured, or whose physical integrity is threatened.The incidence of PTSD has been reported inconsistently, with women more likely to develop PTSD than men.

The global Post-Traumatic Stress Disorder (PTSD) market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

North American market for Post-Traumatic Stress Disorder (PTSD) is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

Asia-Pacific market for Post-Traumatic Stress Disorder (PTSD) is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The global market for Post-Traumatic Stress Disorder (PTSD) in Children is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The key global companies of Post-Traumatic Stress Disorder (PTSD) include GlaxoSmithKline (UK), Pfizer (US), Eli Lilly and Company (US), Lundbeck A/S (Denmark), Azevan Pharmaceuticals (US), Marinus Pharmaceuticals, Inc. (US), Tonix Pharmaceuticals Holding Corp. (US), Bionomics (Australia) and Greenstone LLC (US), etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Post-Traumatic Stress Disorder (PTSD), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Post-Traumatic Stress Disorder (PTSD).

The Post-Traumatic Stress Disorder (PTSD) market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Post-Traumatic Stress Disorder (PTSD) market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Post-Traumatic Stress Disorder (PTSD) companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.

Scope of Post-Traumatic Stress Disorder (PTSD) Market Report

Core Chapters

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Post-Traumatic Stress Disorder (PTSD) Market Size Growth Rate by Type: 2018 VS 2022 VS 2029

1.2.2 Cognitive Therapy

1.2.3 Exposure Therapy

1.2.4 Eye Movement Desensitization And Reprocessing (EMDR)

1.2.5 Antidepressants

1.2.6 Anti-Anxiety Medications

1.2.7 Prazosin

1.3 Market by Application

1.3.1 Global Post-Traumatic Stress Disorder (PTSD) Market Growth by Application: 2018 VS 2022 VS 2029

1.3.2 Children

1.3.3 Adult

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2.1 Global Post-Traumatic Stress Disorder (PTSD) Market Perspective (2018-2029)

2.2 Post-Traumatic Stress Disorder (PTSD) Growth Trends by Region

2.2.1 Global Post-Traumatic Stress Disorder (PTSD) Market Size by Region: 2018 VS 2022 VS 2029

2.2.2 Post-Traumatic Stress Disorder (PTSD) Historic Market Size by Region (2018-2023)

2.2.3 Post-Traumatic Stress Disorder (PTSD) Forecasted Market Size by Region (2024-2029)

2.3 Post-Traumatic Stress Disorder (PTSD) Market Dynamics

2.3.1 Post-Traumatic Stress Disorder (PTSD) Industry Trends

2.3.2 Post-Traumatic Stress Disorder (PTSD) Market Drivers

2.3.3 Post-Traumatic Stress Disorder (PTSD) Market Challenges

2.3.4 Post-Traumatic Stress Disorder (PTSD) Market Restraints

3.1 Global Top Post-Traumatic Stress Disorder (PTSD) Players by Revenue

3.1.1 Global Top Post-Traumatic Stress Disorder (PTSD) Players by Revenue (2018-2023)

3.1.2 Global Post-Traumatic Stress Disorder (PTSD) Revenue Market Share by Players (2018-2023)

3.2 Global Post-Traumatic Stress Disorder (PTSD) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Post-Traumatic Stress Disorder (PTSD) Revenue

3.4 Global Post-Traumatic Stress Disorder (PTSD) Market Concentration Ratio

3.4.1 Global Post-Traumatic Stress Disorder (PTSD) Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Post-Traumatic Stress Disorder (PTSD) Revenue in 2022

3.5 Post-Traumatic Stress Disorder (PTSD) Key Players Head office and Area Served

3.6 Key Players Post-Traumatic Stress Disorder (PTSD) Product Solution and Service

3.7 Date of Enter into Post-Traumatic Stress Disorder (PTSD) Market

3.8 Mergers & Acquisitions, Expansion Plans

4.1 Global Post-Traumatic Stress Disorder (PTSD) Historic Market Size by Type (2018-2023)

4.2 Global Post-Traumatic Stress Disorder (PTSD) Forecasted Market Size by Type (2024-2029)

5.1 Global Post-Traumatic Stress Disorder (PTSD) Historic Market Size by Application (2018-2023)

5.2 Global Post-Traumatic Stress Disorder (PTSD) Forecasted Market Size by Application (2024-2029)

6.1 North America Post-Traumatic Stress Disorder (PTSD) Market Size (2018-2029)

6.2 North America Post-Traumatic Stress Disorder (PTSD) Market Growth Rate by Country: 2018 VS 2022 VS 2029

6.3 North America Post-Traumatic Stress Disorder (PTSD) Market Size by Country (2018-2023)

6.4 North America Post-Traumatic Stress Disorder (PTSD) Market Size by Country (2024-2029)

6.5 United States

6.6 Canada

7.1 Europe Post-Traumatic Stress Disorder (PTSD) Market Size (2018-2029)

7.2 Europe Post-Traumatic Stress Disorder (PTSD) Market Growth Rate by Country: 2018 VS 2022 VS 2029

7.3 Europe Post-Traumatic Stress Disorder (PTSD) Market Size by Country (2018-2023)

7.4 Europe Post-Traumatic Stress Disorder (PTSD) Market Size by Country (2024-2029)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8.1 Asia-Pacific Post-Traumatic Stress Disorder (PTSD) Market Size (2018-2029)

8.2 Asia-Pacific Post-Traumatic Stress Disorder (PTSD) Market Growth Rate by Region: 2018 VS 2022 VS 2029

8.3 Asia-Pacific Post-Traumatic Stress Disorder (PTSD) Market Size by Region (2018-2023)

8.4 Asia-Pacific Post-Traumatic Stress Disorder (PTSD) Market Size by Region (2024-2029)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9.1 Latin America Post-Traumatic Stress Disorder (PTSD) Market Size (2018-2029)

9.2 Latin America Post-Traumatic Stress Disorder (PTSD) Market Growth Rate by Country: 2018 VS 2022 VS 2029

9.3 Latin America Post-Traumatic Stress Disorder (PTSD) Market Size by Country (2018-2023)

9.4 Latin America Post-Traumatic Stress Disorder (PTSD) Market Size by Country (2024-2029)

9.5 Mexico

9.6 Brazil

10.1 Middle East & Africa Post-Traumatic Stress Disorder (PTSD) Market Size (2018-2029)

10.2 Middle East & Africa Post-Traumatic Stress Disorder (PTSD) Market Growth Rate by Country: 2018 VS 2022 VS 2029

10.3 Middle East & Africa Post-Traumatic Stress Disorder (PTSD) Market Size by Country (2018-2023)

10.4 Middle East & Africa Post-Traumatic Stress Disorder (PTSD) Market Size by Country (2024-2029)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11.1 GlaxoSmithKline (UK)

11.1.1 GlaxoSmithKline (UK) Company Detail

11.1.2 GlaxoSmithKline (UK) Business Overview

11.1.3 GlaxoSmithKline (UK) Post-Traumatic Stress Disorder (PTSD) Introduction

11.1.4 GlaxoSmithKline (UK) Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2018-2023)

11.1.5 GlaxoSmithKline (UK) Recent Development

11.2 Pfizer (US)

11.2.1 Pfizer (US) Company Detail

11.2.2 Pfizer (US) Business Overview

11.2.3 Pfizer (US) Post-Traumatic Stress Disorder (PTSD) Introduction

11.2.4 Pfizer (US) Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2018-2023)

11.2.5 Pfizer (US) Recent Development

11.3 Eli Lilly and Company (US)

11.3.1 Eli Lilly and Company (US) Company Detail

11.3.2 Eli Lilly and Company (US) Business Overview

11.3.3 Eli Lilly and Company (US) Post-Traumatic Stress Disorder (PTSD) Introduction

11.3.4 Eli Lilly and Company (US) Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2018-2023)

11.3.5 Eli Lilly and Company (US) Recent Development

11.4 Lundbeck A/S (Denmark)

11.4.1 Lundbeck A/S (Denmark) Company Detail

11.4.2 Lundbeck A/S (Denmark) Business Overview

11.4.3 Lundbeck A/S (Denmark) Post-Traumatic Stress Disorder (PTSD) Introduction

11.4.4 Lundbeck A/S (Denmark) Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2018-2023)

11.4.5 Lundbeck A/S (Denmark) Recent Development

11.5 Azevan Pharmaceuticals (US)

11.5.1 Azevan Pharmaceuticals (US) Company Detail

11.5.2 Azevan Pharmaceuticals (US) Business Overview

11.5.3 Azevan Pharmaceuticals (US) Post-Traumatic Stress Disorder (PTSD) Introduction

11.5.4 Azevan Pharmaceuticals (US) Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2018-2023)

11.5.5 Azevan Pharmaceuticals (US) Recent Development

11.6 Marinus Pharmaceuticals, Inc. (US)

11.6.1 Marinus Pharmaceuticals, Inc. (US) Company Detail

11.6.2 Marinus Pharmaceuticals, Inc. (US) Business Overview

11.6.3 Marinus Pharmaceuticals, Inc. (US) Post-Traumatic Stress Disorder (PTSD) Introduction

11.6.4 Marinus Pharmaceuticals, Inc. (US) Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2018-2023)

11.6.5 Marinus Pharmaceuticals, Inc. (US) Recent Development

11.7 Tonix Pharmaceuticals Holding Corp. (US)

11.7.1 Tonix Pharmaceuticals Holding Corp. (US) Company Detail

11.7.2 Tonix Pharmaceuticals Holding Corp. (US) Business Overview

11.7.3 Tonix Pharmaceuticals Holding Corp. (US) Post-Traumatic Stress Disorder (PTSD) Introduction

11.7.4 Tonix Pharmaceuticals Holding Corp. (US) Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2018-2023)

11.7.5 Tonix Pharmaceuticals Holding Corp. (US) Recent Development

11.8 Bionomics (Australia)

11.8.1 Bionomics (Australia) Company Detail

11.8.2 Bionomics (Australia) Business Overview

11.8.3 Bionomics (Australia) Post-Traumatic Stress Disorder (PTSD) Introduction

11.8.4 Bionomics (Australia) Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2018-2023)

11.8.5 Bionomics (Australia) Recent Development

11.9 Greenstone LLC (US)

11.9.1 Greenstone LLC (US) Company Detail

11.9.2 Greenstone LLC (US) Business Overview

11.9.3 Greenstone LLC (US) Post-Traumatic Stress Disorder (PTSD) Introduction

11.9.4 Greenstone LLC (US) Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2018-2023)

11.9.5 Greenstone LLC (US) Recent Development

11.10 Mylan NV (US)

11.10.1 Mylan NV (US) Company Detail

11.10.2 Mylan NV (US) Business Overview

11.10.3 Mylan NV (US) Post-Traumatic Stress Disorder (PTSD) Introduction

11.10.4 Mylan NV (US) Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2018-2023)

11.10.5 Mylan NV (US) Recent Development

11.11 Otsuka Pharmaceutical (Japan)

11.11.1 Otsuka Pharmaceutical (Japan) Company Detail

11.11.2 Otsuka Pharmaceutical (Japan) Business Overview

11.11.3 Otsuka Pharmaceutical (Japan) Post-Traumatic Stress Disorder (PTSD) Introduction

11.11.4 Otsuka Pharmaceutical (Japan) Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2018-2023)

11.11.5 Otsuka Pharmaceutical (Japan) Recent Development

11.12 Prometheon Pharma (USA)

11.12.1 Prometheon Pharma (USA) Company Detail

11.12.2 Prometheon Pharma (USA) Business Overview

11.12.3 Prometheon Pharma (USA) Post-Traumatic Stress Disorder (PTSD) Introduction

11.12.4 Prometheon Pharma (USA) Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2018-2023)

11.12.5 Prometheon Pharma (USA) Recent Development

11.13 Ligand Pharma (USA)

11.13.1 Ligand Pharma (USA) Company Detail

11.13.2 Ligand Pharma (USA) Business Overview

11.13.3 Ligand Pharma (USA) Post-Traumatic Stress Disorder (PTSD) Introduction

11.13.4 Ligand Pharma (USA) Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2018-2023)

11.13.5 Ligand Pharma (USA) Recent Development

11.14 Valenta Pharm (Russia)

11.14.1 Valenta Pharm (Russia) Company Detail

11.14.2 Valenta Pharm (Russia) Business Overview

11.14.3 Valenta Pharm (Russia) Post-Traumatic Stress Disorder (PTSD) Introduction

11.14.4 Valenta Pharm (Russia) Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2018-2023)

11.14.5 Valenta Pharm (Russia) Recent Development

11.15 Lycera Corp (US)

11.15.1 Lycera Corp (US) Company Detail

11.15.2 Lycera Corp (US) Business Overview

11.15.3 Lycera Corp (US) Post-Traumatic Stress Disorder (PTSD) Introduction

11.15.4 Lycera Corp (US) Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2018-2023)

11.15.5 Lycera Corp (US) Recent Development

11.16 Archimedes (UK)

11.16.1 Archimedes (UK) Company Detail

11.16.2 Archimedes (UK) Business Overview

11.16.3 Archimedes (UK) Post-Traumatic Stress Disorder (PTSD) Introduction

11.16.4 Archimedes (UK) Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2018-2023)

11.16.5 Archimedes (UK) Recent Development

11.17 GMP Endotherapeutics (USA)

11.17.1 GMP Endotherapeutics (USA) Company Detail

11.17.2 GMP Endotherapeutics (USA) Business Overview

11.17.3 GMP Endotherapeutics (USA) Post-Traumatic Stress Disorder (PTSD) Introduction

11.17.4 GMP Endotherapeutics (USA) Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2018-2023)

11.17.5 GMP Endotherapeutics (USA) Recent Development

11.18 Nuvo Pharmaceuticals (Canada)

11.18.1 Nuvo Pharmaceuticals (Canada) Company Detail

11.18.2 Nuvo Pharmaceuticals (Canada) Business Overview

11.18.3 Nuvo Pharmaceuticals (Canada) Post-Traumatic Stress Disorder (PTSD) Introduction

11.18.4 Nuvo Pharmaceuticals (Canada) Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2018-2023)

11.18.5 Nuvo Pharmaceuticals (Canada) Recent Development

11.19 Beijing Wansheng Pharmaceutical

11.19.1 Beijing Wansheng Pharmaceutical Company Detail

11.19.2 Beijing Wansheng Pharmaceutical Business Overview

11.19.3 Beijing Wansheng Pharmaceutical Post-Traumatic Stress Disorder (PTSD) Introduction

11.19.4 Beijing Wansheng Pharmaceutical Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2018-2023)

11.19.5 Beijing Wansheng Pharmaceutical Recent Development

11.20 Zhejiang Huahai Pharmaceutical

11.20.1 Zhejiang Huahai Pharmaceutical Company Detail

11.20.2 Zhejiang Huahai Pharmaceutical Business Overview

11.20.3 Zhejiang Huahai Pharmaceutical Post-Traumatic Stress Disorder (PTSD) Introduction

11.20.4 Zhejiang Huahai Pharmaceutical Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2018-2023)

11.20.5 Zhejiang Huahai Pharmaceutical Recent Development

11.21 Zhejiang Jianfeng Pharmaceutical

11.21.1 Zhejiang Jianfeng Pharmaceutical Company Detail

11.21.2 Zhejiang Jianfeng Pharmaceutical Business Overview

11.21.3 Zhejiang Jianfeng Pharmaceutical Post-Traumatic Stress Disorder (PTSD) Introduction

11.21.4 Zhejiang Jianfeng Pharmaceutical Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2018-2023)

11.21.5 Zhejiang Jianfeng Pharmaceutical Recent Development

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

List of Tables

    Table 1. Global Post-Traumatic Stress Disorder (PTSD) Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029

    Table 2. Key Players of Cognitive Therapy

    Table 3. Key Players of Exposure Therapy

    Table 4. Key Players of Eye Movement Desensitization And Reprocessing (EMDR)

    Table 5. Key Players of Antidepressants

    Table 6. Key Players of Anti-Anxiety Medications

    Table 7. Key Players of Prazosin

    Table 8. Global Post-Traumatic Stress Disorder (PTSD) Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029

    Table 9. Global Post-Traumatic Stress Disorder (PTSD) Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 10. Global Post-Traumatic Stress Disorder (PTSD) Market Size by Region (2018-2023) & (US$ Million)

    Table 11. Global Post-Traumatic Stress Disorder (PTSD) Market Share by Region (2018-2023)

    Table 12. Global Post-Traumatic Stress Disorder (PTSD) Forecasted Market Size by Region (2024-2029) & (US$ Million)

    Table 13. Global Post-Traumatic Stress Disorder (PTSD) Market Share by Region (2024-2029)

    Table 14. Post-Traumatic Stress Disorder (PTSD) Market Trends

    Table 15. Post-Traumatic Stress Disorder (PTSD) Market Drivers

    Table 16. Post-Traumatic Stress Disorder (PTSD) Market Challenges

    Table 17. Post-Traumatic Stress Disorder (PTSD) Market Restraints

    Table 18. Global Post-Traumatic Stress Disorder (PTSD) Revenue by Players (2018-2023) & (US$ Million)

    Table 19. Global Post-Traumatic Stress Disorder (PTSD) Market Share by Players (2018-2023)

    Table 20. Global Top Post-Traumatic Stress Disorder (PTSD) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Post-Traumatic Stress Disorder (PTSD) as of 2022)

    Table 21. Ranking of Global Top Post-Traumatic Stress Disorder (PTSD) Companies by Revenue (US$ Million) in 2022

    Table 22. Global 5 Largest Players Market Share by Post-Traumatic Stress Disorder (PTSD) Revenue (CR5 and HHI) & (2018-2023)

    Table 23. Key Players Headquarters and Area Served

    Table 24. Key Players Post-Traumatic Stress Disorder (PTSD) Product Solution and Service

    Table 25. Date of Enter into Post-Traumatic Stress Disorder (PTSD) Market

    Table 26. Mergers & Acquisitions, Expansion Plans

    Table 27. Global Post-Traumatic Stress Disorder (PTSD) Market Size by Type (2018-2023) & (US$ Million)

    Table 28. Global Post-Traumatic Stress Disorder (PTSD) Revenue Market Share by Type (2018-2023)

    Table 29. Global Post-Traumatic Stress Disorder (PTSD) Forecasted Market Size by Type (2024-2029) & (US$ Million)

    Table 30. Global Post-Traumatic Stress Disorder (PTSD) Revenue Market Share by Type (2024-2029)

    Table 31. Global Post-Traumatic Stress Disorder (PTSD) Market Size by Application (2018-2023) & (US$ Million)

    Table 32. Global Post-Traumatic Stress Disorder (PTSD) Revenue Market Share by Application (2018-2023)

    Table 33. Global Post-Traumatic Stress Disorder (PTSD) Forecasted Market Size by Application (2024-2029) & (US$ Million)

    Table 34. Global Post-Traumatic Stress Disorder (PTSD) Revenue Market Share by Application (2024-2029)

    Table 35. North America Post-Traumatic Stress Disorder (PTSD) Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 36. North America Post-Traumatic Stress Disorder (PTSD) Market Size by Country (2018-2023) & (US$ Million)

    Table 37. North America Post-Traumatic Stress Disorder (PTSD) Market Size by Country (2024-2029) & (US$ Million)

    Table 38. Europe Post-Traumatic Stress Disorder (PTSD) Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 39. Europe Post-Traumatic Stress Disorder (PTSD) Market Size by Country (2018-2023) & (US$ Million)

    Table 40. Europe Post-Traumatic Stress Disorder (PTSD) Market Size by Country (2024-2029) & (US$ Million)

    Table 41. Asia-Pacific Post-Traumatic Stress Disorder (PTSD) Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 42. Asia-Pacific Post-Traumatic Stress Disorder (PTSD) Market Size by Region (2018-2023) & (US$ Million)

    Table 43. Asia-Pacific Post-Traumatic Stress Disorder (PTSD) Market Size by Region (2024-2029) & (US$ Million)

    Table 44. Latin America Post-Traumatic Stress Disorder (PTSD) Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 45. Latin America Post-Traumatic Stress Disorder (PTSD) Market Size by Country (2018-2023) & (US$ Million)

    Table 46. Latin America Post-Traumatic Stress Disorder (PTSD) Market Size by Country (2024-2029) & (US$ Million)

    Table 47. Middle East & Africa Post-Traumatic Stress Disorder (PTSD) Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 48. Middle East & Africa Post-Traumatic Stress Disorder (PTSD) Market Size by Country (2018-2023) & (US$ Million)

    Table 49. Middle East & Africa Post-Traumatic Stress Disorder (PTSD) Market Size by Country (2024-2029) & (US$ Million)

    Table 50. GlaxoSmithKline (UK) Company Detail

    Table 51. GlaxoSmithKline (UK) Business Overview

    Table 52. GlaxoSmithKline (UK) Post-Traumatic Stress Disorder (PTSD) Product

    Table 53. GlaxoSmithKline (UK) Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2018-2023) & (US$ Million)

    Table 54. GlaxoSmithKline (UK) Recent Development

    Table 55. Pfizer (US) Company Detail

    Table 56. Pfizer (US) Business Overview

    Table 57. Pfizer (US) Post-Traumatic Stress Disorder (PTSD) Product

    Table 58. Pfizer (US) Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2018-2023) & (US$ Million)

    Table 59. Pfizer (US) Recent Development

    Table 60. Eli Lilly and Company (US) Company Detail

    Table 61. Eli Lilly and Company (US) Business Overview

    Table 62. Eli Lilly and Company (US) Post-Traumatic Stress Disorder (PTSD) Product

    Table 63. Eli Lilly and Company (US) Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2018-2023) & (US$ Million)

    Table 64. Eli Lilly and Company (US) Recent Development

    Table 65. Lundbeck A/S (Denmark) Company Detail

    Table 66. Lundbeck A/S (Denmark) Business Overview

    Table 67. Lundbeck A/S (Denmark) Post-Traumatic Stress Disorder (PTSD) Product

    Table 68. Lundbeck A/S (Denmark) Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2018-2023) & (US$ Million)

    Table 69. Lundbeck A/S (Denmark) Recent Development

    Table 70. Azevan Pharmaceuticals (US) Company Detail

    Table 71. Azevan Pharmaceuticals (US) Business Overview

    Table 72. Azevan Pharmaceuticals (US) Post-Traumatic Stress Disorder (PTSD) Product

    Table 73. Azevan Pharmaceuticals (US) Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2018-2023) & (US$ Million)

    Table 74. Azevan Pharmaceuticals (US) Recent Development

    Table 75. Marinus Pharmaceuticals, Inc. (US) Company Detail

    Table 76. Marinus Pharmaceuticals, Inc. (US) Business Overview

    Table 77. Marinus Pharmaceuticals, Inc. (US) Post-Traumatic Stress Disorder (PTSD) Product

    Table 78. Marinus Pharmaceuticals, Inc. (US) Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2018-2023) & (US$ Million)

    Table 79. Marinus Pharmaceuticals, Inc. (US) Recent Development

    Table 80. Tonix Pharmaceuticals Holding Corp. (US) Company Detail

    Table 81. Tonix Pharmaceuticals Holding Corp. (US) Business Overview

    Table 82. Tonix Pharmaceuticals Holding Corp. (US) Post-Traumatic Stress Disorder (PTSD) Product

    Table 83. Tonix Pharmaceuticals Holding Corp. (US) Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2018-2023) & (US$ Million)

    Table 84. Tonix Pharmaceuticals Holding Corp. (US) Recent Development

    Table 85. Bionomics (Australia) Company Detail

    Table 86. Bionomics (Australia) Business Overview

    Table 87. Bionomics (Australia) Post-Traumatic Stress Disorder (PTSD) Product

    Table 88. Bionomics (Australia) Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2018-2023) & (US$ Million)

    Table 89. Bionomics (Australia) Recent Development

    Table 90. Greenstone LLC (US) Company Detail

    Table 91. Greenstone LLC (US) Business Overview

    Table 92. Greenstone LLC (US) Post-Traumatic Stress Disorder (PTSD) Product

    Table 93. Greenstone LLC (US) Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2018-2023) & (US$ Million)

    Table 94. Greenstone LLC (US) Recent Development

    Table 95. Mylan NV (US) Company Detail

    Table 96. Mylan NV (US) Business Overview

    Table 97. Mylan NV (US) Post-Traumatic Stress Disorder (PTSD) Product

    Table 98. Mylan NV (US) Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2018-2023) & (US$ Million)

    Table 99. Mylan NV (US) Recent Development

    Table 100. Otsuka Pharmaceutical (Japan) Company Detail

    Table 101. Otsuka Pharmaceutical (Japan) Business Overview

    Table 102. Otsuka Pharmaceutical (Japan) Post-Traumatic Stress Disorder (PTSD) Product

    Table 103. Otsuka Pharmaceutical (Japan) Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2018-2023) & (US$ Million)

    Table 104. Otsuka Pharmaceutical (Japan) Recent Development

    Table 105. Prometheon Pharma (USA) Company Detail

    Table 106. Prometheon Pharma (USA) Business Overview

    Table 107. Prometheon Pharma (USA) Post-Traumatic Stress Disorder (PTSD) Product

    Table 108. Prometheon Pharma (USA) Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2018-2023) & (US$ Million)

    Table 109. Prometheon Pharma (USA) Recent Development

    Table 110. Ligand Pharma (USA) Company Detail

    Table 111. Ligand Pharma (USA) Business Overview

    Table 112. Ligand Pharma (USA) Post-Traumatic Stress Disorder (PTSD) Product

    Table 113. Ligand Pharma (USA) Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2018-2023) & (US$ Million)

    Table 114. Ligand Pharma (USA) Recent Development

    Table 115. Valenta Pharm (Russia) Company Detail

    Table 116. Valenta Pharm (Russia) Business Overview

    Table 117. Valenta Pharm (Russia) Post-Traumatic Stress Disorder (PTSD) Product

    Table 118. Valenta Pharm (Russia) Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2018-2023) & (US$ Million)

    Table 119. Valenta Pharm (Russia) Recent Development

    Table 120. Lycera Corp (US) Company Detail

    Table 121. Lycera Corp (US) Business Overview

    Table 122. Lycera Corp (US) Post-Traumatic Stress Disorder (PTSD) Product

    Table 123. Lycera Corp (US) Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2018-2023) & (US$ Million)

    Table 124. Lycera Corp (US) Recent Development

    Table 125. Archimedes (UK) Company Detail

    Table 126. Archimedes (UK) Business Overview

    Table 127. Archimedes (UK) Post-Traumatic Stress Disorder (PTSD) Product

    Table 128. Archimedes (UK) Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2018-2023) & (US$ Million)

    Table 129. Archimedes (UK) Recent Development

    Table 130. GMP Endotherapeutics (USA) Company Detail

    Table 131. GMP Endotherapeutics (USA) Business Overview

    Table 132. GMP Endotherapeutics (USA) Post-Traumatic Stress Disorder (PTSD) Product

    Table 133. GMP Endotherapeutics (USA) Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2018-2023) & (US$ Million)

    Table 134. GMP Endotherapeutics (USA) Recent Development

    Table 135. Nuvo Pharmaceuticals (Canada) Company Detail

    Table 136. Nuvo Pharmaceuticals (Canada) Business Overview

    Table 137. Nuvo Pharmaceuticals (Canada) Post-Traumatic Stress Disorder (PTSD) Product

    Table 138. Nuvo Pharmaceuticals (Canada) Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2018-2023) & (US$ Million)

    Table 139. Nuvo Pharmaceuticals (Canada) Recent Development

    Table 140. Beijing Wansheng Pharmaceutical Company Detail

    Table 141. Beijing Wansheng Pharmaceutical Business Overview

    Table 142. Beijing Wansheng Pharmaceutical Post-Traumatic Stress Disorder (PTSD) Product

    Table 143. Beijing Wansheng Pharmaceutical Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2018-2023) & (US$ Million)

    Table 144. Beijing Wansheng Pharmaceutical Recent Development

    Table 145. Zhejiang Huahai Pharmaceutical Company Detail

    Table 146. Zhejiang Huahai Pharmaceutical Business Overview

    Table 147. Zhejiang Huahai Pharmaceutical Post-Traumatic Stress Disorder (PTSD) Product

    Table 148. Zhejiang Huahai Pharmaceutical Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2018-2023) & (US$ Million)

    Table 149. Zhejiang Huahai Pharmaceutical Recent Development

    Table 150. Zhejiang Jianfeng Pharmaceutical Company Detail

    Table 151. Zhejiang Jianfeng Pharmaceutical Business Overview

    Table 152. Zhejiang Jianfeng Pharmaceutical Post-Traumatic Stress Disorder (PTSD) Product

    Table 153. Zhejiang Jianfeng Pharmaceutical Revenue in Post-Traumatic Stress Disorder (PTSD) Business (2018-2023) & (US$ Million)

    Table 154. Zhejiang Jianfeng Pharmaceutical Recent Development

    Table 155. Research Programs/Design for This Report

    Table 156. Key Data Information from Secondary Sources

    Table 157. Key Data Information from Primary Sources

List of Figures

    Figure 1. Global Post-Traumatic Stress Disorder (PTSD) Market Size Comparison by Type (2023-2029) & (US$ Million)

    Figure 2. Global Post-Traumatic Stress Disorder (PTSD) Market Share by Type: 2022 VS 2029

    Figure 3. Cognitive Therapy Features

    Figure 4. Exposure Therapy Features

    Figure 5. Eye Movement Desensitization And Reprocessing (EMDR) Features

    Figure 6. Antidepressants Features

    Figure 7. Anti-Anxiety Medications Features

    Figure 8. Prazosin Features

    Figure 9. Global Post-Traumatic Stress Disorder (PTSD) Market Size Comparison by Application (2023-2029) & (US$ Million)

    Figure 10. Global Post-Traumatic Stress Disorder (PTSD) Market Share by Application: 2022 VS 2029

    Figure 11. Children Case Studies

    Figure 12. Adult Case Studies

    Figure 13. Post-Traumatic Stress Disorder (PTSD) Report Years Considered

    Figure 14. Global Post-Traumatic Stress Disorder (PTSD) Market Size (US$ Million), Year-over-Year: 2018-2029

    Figure 15. Global Post-Traumatic Stress Disorder (PTSD) Market Size, (US$ Million), 2018 VS 2022 VS 2029

    Figure 16. Global Post-Traumatic Stress Disorder (PTSD) Market Share by Region: 2022 VS 2029

    Figure 17. Global Post-Traumatic Stress Disorder (PTSD) Market Share by Players in 2022

    Figure 18. Global Top Post-Traumatic Stress Disorder (PTSD) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Post-Traumatic Stress Disorder (PTSD) as of 2022)

    Figure 19. The Top 10 and 5 Players Market Share by Post-Traumatic Stress Disorder (PTSD) Revenue in 2022

    Figure 20. North America Post-Traumatic Stress Disorder (PTSD) Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 21. North America Post-Traumatic Stress Disorder (PTSD) Market Share by Country (2018-2029)

    Figure 22. United States Post-Traumatic Stress Disorder (PTSD) Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 23. Canada Post-Traumatic Stress Disorder (PTSD) Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 24. Europe Post-Traumatic Stress Disorder (PTSD) Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 25. Europe Post-Traumatic Stress Disorder (PTSD) Market Share by Country (2018-2029)

    Figure 26. Germany Post-Traumatic Stress Disorder (PTSD) Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 27. France Post-Traumatic Stress Disorder (PTSD) Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 28. U.K. Post-Traumatic Stress Disorder (PTSD) Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 29. Italy Post-Traumatic Stress Disorder (PTSD) Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 30. Russia Post-Traumatic Stress Disorder (PTSD) Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 31. Nordic Countries Post-Traumatic Stress Disorder (PTSD) Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 32. Asia-Pacific Post-Traumatic Stress Disorder (PTSD) Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 33. Asia-Pacific Post-Traumatic Stress Disorder (PTSD) Market Share by Region (2018-2029)

    Figure 34. China Post-Traumatic Stress Disorder (PTSD) Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 35. Japan Post-Traumatic Stress Disorder (PTSD) Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 36. South Korea Post-Traumatic Stress Disorder (PTSD) Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 37. Southeast Asia Post-Traumatic Stress Disorder (PTSD) Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 38. India Post-Traumatic Stress Disorder (PTSD) Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 39. Australia Post-Traumatic Stress Disorder (PTSD) Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 40. Latin America Post-Traumatic Stress Disorder (PTSD) Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 41. Latin America Post-Traumatic Stress Disorder (PTSD) Market Share by Country (2018-2029)

    Figure 42. Mexico Post-Traumatic Stress Disorder (PTSD) Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 43. Brazil Post-Traumatic Stress Disorder (PTSD) Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 44. Middle East & Africa Post-Traumatic Stress Disorder (PTSD) Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 45. Middle East & Africa Post-Traumatic Stress Disorder (PTSD) Market Share by Country (2018-2029)

    Figure 46. Turkey Post-Traumatic Stress Disorder (PTSD) Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 47. Saudi Arabia Post-Traumatic Stress Disorder (PTSD) Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 48. GlaxoSmithKline (UK) Revenue Growth Rate in Post-Traumatic Stress Disorder (PTSD) Business (2018-2023)

    Figure 49. Pfizer (US) Revenue Growth Rate in Post-Traumatic Stress Disorder (PTSD) Business (2018-2023)

    Figure 50. Eli Lilly and Company (US) Revenue Growth Rate in Post-Traumatic Stress Disorder (PTSD) Business (2018-2023)

    Figure 51. Lundbeck A/S (Denmark) Revenue Growth Rate in Post-Traumatic Stress Disorder (PTSD) Business (2018-2023)

    Figure 52. Azevan Pharmaceuticals (US) Revenue Growth Rate in Post-Traumatic Stress Disorder (PTSD) Business (2018-2023)

    Figure 53. Marinus Pharmaceuticals, Inc. (US) Revenue Growth Rate in Post-Traumatic Stress Disorder (PTSD) Business (2018-2023)

    Figure 54. Tonix Pharmaceuticals Holding Corp. (US) Revenue Growth Rate in Post-Traumatic Stress Disorder (PTSD) Business (2018-2023)

    Figure 55. Bionomics (Australia) Revenue Growth Rate in Post-Traumatic Stress Disorder (PTSD) Business (2018-2023)

    Figure 56. Greenstone LLC (US) Revenue Growth Rate in Post-Traumatic Stress Disorder (PTSD) Business (2018-2023)

    Figure 57. Mylan NV (US) Revenue Growth Rate in Post-Traumatic Stress Disorder (PTSD) Business (2018-2023)

    Figure 58. Otsuka Pharmaceutical (Japan) Revenue Growth Rate in Post-Traumatic Stress Disorder (PTSD) Business (2018-2023)

    Figure 59. Prometheon Pharma (USA) Revenue Growth Rate in Post-Traumatic Stress Disorder (PTSD) Business (2018-2023)

    Figure 60. Ligand Pharma (USA) Revenue Growth Rate in Post-Traumatic Stress Disorder (PTSD) Business (2018-2023)

    Figure 61. Valenta Pharm (Russia) Revenue Growth Rate in Post-Traumatic Stress Disorder (PTSD) Business (2018-2023)

    Figure 62. Lycera Corp (US) Revenue Growth Rate in Post-Traumatic Stress Disorder (PTSD) Business (2018-2023)

    Figure 63. Archimedes (UK) Revenue Growth Rate in Post-Traumatic Stress Disorder (PTSD) Business (2018-2023)

    Figure 64. GMP Endotherapeutics (USA) Revenue Growth Rate in Post-Traumatic Stress Disorder (PTSD) Business (2018-2023)

    Figure 65. Nuvo Pharmaceuticals (Canada) Revenue Growth Rate in Post-Traumatic Stress Disorder (PTSD) Business (2018-2023)

    Figure 66. Beijing Wansheng Pharmaceutical Revenue Growth Rate in Post-Traumatic Stress Disorder (PTSD) Business (2018-2023)

    Figure 67. Zhejiang Huahai Pharmaceutical Revenue Growth Rate in Post-Traumatic Stress Disorder (PTSD) Business (2018-2023)

    Figure 68. Zhejiang Jianfeng Pharmaceutical Revenue Growth Rate in Post-Traumatic Stress Disorder (PTSD) Business (2018-2023)

    Figure 69. Bottom-up and Top-down Approaches for This Report

    Figure 70. Data Triangulation

    Figure 71. Key Executives Interviewed